NO970273L - Peptid-avledete radionuklid-chelatorer - Google Patents

Peptid-avledete radionuklid-chelatorer

Info

Publication number: NO970273L
Authority: NO; Norway
Prior art keywords: alkyl; carboxyl; hydroxyl; amino; halogen
Prior art date: 1994-07-22

Application number

NO970273A

Other languages

English (en)

Norwegian (no)

Other versions

NO970273D0 (no

Inventor

Alfred Pollak

Anne Goodbody

Original Assignee

Resolution Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-22

Filing date

1997-01-21

Publication date

1997-03-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23067872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO970273(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-01-21 Application filed by Resolution Pharm Inc filed Critical Resolution Pharm Inc

1997-01-21 Publication of NO970273D0 publication Critical patent/NO970273D0/no

1997-03-12 Publication of NO970273L publication Critical patent/NO970273L/no

Links

239000002738 chelating agent Substances 0.000 title abstract 2
108090000765 processed proteins & peptides Proteins 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 5
229910052736 halogen Inorganic materials 0.000 abstract 3
150000002367 halogens Chemical class 0.000 abstract 3
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
-1 amino, carboxyl Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
229920006395 saturated elastomer Polymers 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
230000008685 targeting Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

NO970273A 1994-07-22 1997-01-21 Peptid-avledete radionuklid-chelatorer NO970273L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/279,155 US5662885A (en)	1994-07-22	1994-07-22	Peptide derived radionuclide chelators
PCT/CA1995/000249 WO1996003427A1 (en)	1994-07-22	1995-04-28	Peptide derived radionuclide chelators

Publications (2)

Publication Number	Publication Date
NO970273D0 NO970273D0 (no)	1997-01-21
NO970273L true NO970273L (no)	1997-03-12

Family

ID=23067872

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO970273A NO970273L (no)	1994-07-22	1997-01-21	Peptid-avledete radionuklid-chelatorer

Country Status (11)

Country	Link
US (3)	US5662885A (de)
EP (1)	EP0772628B1 (de)
JP (1)	JP3753734B2 (de)
CN (1)	CN1158133A (de)
AT (1)	ATE194845T1 (de)
AU (1)	AU700772B2 (de)
CA (1)	CA2194551A1 (de)
DE (1)	DE69518083T2 (de)
HU (1)	HUT77137A (de)
NO (1)	NO970273L (de)
WO (1)	WO1996003427A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7238340B1 (en)	1991-11-27	2007-07-03	Cis Bio International	Monoamine, diamide, thiol-containing metal chelating agents
US5645815A (en) *	1991-02-08	1997-07-08	Diatide, Inc.	Radiolabled compounds for thrombus imaging
US5662885A (en) *	1994-07-22	1997-09-02	Resolution Pharmaceuticals Inc.	Peptide derived radionuclide chelators
US5804158A (en) *	1995-05-31	1998-09-08	Resolution Pharmaceuticals Inc.	Sequestered imaging agents
US6027711A (en) *	1995-06-07	2000-02-22	Rhomed Incorporated	Structurally determined metallo-constructs and applications
US5688489A (en) *	1995-09-15	1997-11-18	Resolution Pharmaceuticals, Inc.	Non-receptor mediated imaging agents
FR2748747B1 (fr) *	1996-05-20	1998-08-07	Centre Nat Rech Scient	Particules virales recombinantes comportant un peptide ayant des proprietes de masquage et de demasquage vis-a-vis d'un mecanisme biologique
AU3474997A (en) *	1996-06-10	1998-01-07	G.D. Searle & Co.	Radiopharmaceutical compositions capable of localizing at sites of thrombus
JP2002506424A (ja)	1997-04-22	2002-02-26	キュレイターオブザユニバーシィティオブミズーリ	ガストリン受容体−親和性ペプチド結合体
US7060247B2 (en)	1997-04-22	2006-06-13	The Curators Of The University Of Missouri	Gastrin receptor-avid peptide conjugates
US6017511A (en) *	1997-05-30	2000-01-25	Resolution Pharmaceuticals Inc.	Glycopeptide-chelator conjugates
AU8849398A (en) *	1997-08-21	1999-03-16	Resolution Pharmaceuticals Inc.	Combinatorial library
EP1047708B1 (de) *	1997-12-24	2007-09-26	Bracco International B.V.	Peptide chelatoren die nach der koordination mit einem metall zu einem vorherrschenden einzel-stereoisomeren führen
US6334996B1 (en) *	1997-12-24	2002-01-01	Resolution Pharmaceuticals Inc.	Chelators that predominantely form a single stereoisomeric species upon coordination to a metal center
AU3119199A (en)	1998-04-03	1999-10-25	Du Pont Pharmaceuticals Company	Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
AU763092B2 (en) *	1998-08-31	2003-07-10	Gryphon Sciences	Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
EP1141375A4 (de) *	1998-12-14	2002-06-05	Palatin Technologies Inc	Kombinatorische bibliotheken von metallopeptiden und ihre anwendung
CA2362860A1 (en) *	1999-02-17	2000-08-24	Bracco International B.V.	Immobilized labeling compounds and methods
US6544279B1 (en)	2000-08-09	2003-04-08	Incept, Llc	Vascular device for emboli, thrombus and foreign body removal and methods of use
US7482425B2 (en)	1999-08-26	2009-01-27	Amylin Pharmaceuticals, Inc.	Compositions for lipid matrix-assisted chemical ligation
EP2279757A3 (de)	2000-06-02	2011-08-03	Bracco Suisse SA	Arzneimitteln zum Targeting von Endothelzellen
US8263739B2 (en) *	2000-06-02	2012-09-11	Bracco Suisse Sa	Compounds for targeting endothelial cells, compositions containing the same and methods for their use
US7311893B2 (en) *	2000-07-25	2007-12-25	Neurochem (International) Limited	Amyloid targeting imaging agents and uses thereof
CA2429781C (en) *	2000-11-29	2011-01-11	Bracco International B.V.	Linkable sialyl lewis x analogs
US7893223B2 (en)	2001-07-17	2011-02-22	Bracco Imaging S.P.A.	Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
WO2004065621A1 (en)	2002-03-01	2004-08-05	Dyax Corp.	Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
WO2003074005A2 (en)	2002-03-01	2003-09-12	Dyax Corp.	Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en)	2002-03-01	2014-01-07	Bracco Suisse Sa	KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) *	2002-03-01	2010-09-14	Bracco International B.V.	Targeting vector-phospholipid conjugates
US7261876B2 (en)	2002-03-01	2007-08-28	Bracco International Bv	Multivalent constructs for therapeutic and diagnostic applications
US7211240B2 (en)	2002-03-01	2007-05-01	Bracco International B.V.	Multivalent constructs for therapeutic and diagnostic applications
US7922998B2 (en)	2003-01-13	2011-04-12	Bracco Imaging S.P.A.	Gastrin releasing peptide compounds
US8420050B2 (en)	2003-01-13	2013-04-16	Bracco Imaging S.P.A.	Gastrin releasing peptide compounds
US7226577B2 (en)	2003-01-13	2007-06-05	Bracco Imaging, S. P. A.	Gastrin releasing peptide compounds
AU2003303714B2 (en)	2003-01-13	2009-02-19	Bracco Imaging S.P.A.	Improved linkers for radiopharmaceutical compounds
US7611692B2 (en)	2003-01-13	2009-11-03	Bracco Imaging S.P.A.	Gastrin releasing peptide compounds
US7850947B2 (en)	2003-01-13	2010-12-14	Bracco Imaging S.P.A.	Gastrin releasing peptide compounds
US20050214859A1 (en)	2003-03-03	2005-09-29	Dyax Corp.	Peptides that specifically bind HGF receptor (cMet) and uses thereof
JP5139678B2 (ja) *	2003-07-24	2013-02-06	ブラッコ・イメージング・ソシエタ・ペル・アチオニ	安定な放射性医薬品組成物およびその製法
DK1737889T3 (da)	2004-10-19	2011-01-03	Lonza Ag	Fremgangsmåde til fastfase-peptidsyntese
EP1700608A1 (de)	2005-03-10	2006-09-13	Schering AG	Chelate für radioaktiv markierte Konjugate mit einer stabilisierenden Seitenkette
EP2097111B1 (de)	2006-11-08	2015-07-15	Molecular Insight Pharmaceuticals, Inc.	Heterodimere von glutaminsäure
JP5345945B2 (ja)	2006-12-11	2013-11-20	ブラッコ・イメージング・ソシエタ・ペル・アチオニ	フィブリン結合ペプチドおよびそのコンジュゲート
US11260133B2 (en) *	2008-02-21	2022-03-01	Sanford-Burnham Medical Research Institute	Methods and compositions related to peptides and proteins with C-terminal elements
EP2147684A1 (de)	2008-07-22	2010-01-27	Bracco Imaging S.p.A	Selektiv gegen Metallproteasen wirkende Diagnosemittel
US20120045393A1 (en)	2009-03-17	2012-02-23	Linder Karen E	Lhrh-ii peptide analogs
BRPI1015424B1 (pt)	2009-06-22	2022-01-18	Burnham Institute For Medical Research	Composição compreendendo um elemento cendr e uma co-composição e composição para uso no reforço da internalização, penetração, ou ambas, de uma co-composição
WO2015171543A1 (en)	2014-05-05	2015-11-12	California Institute Of Technology	Mutant akt-specific capture agents, compositions, and methods of using and making
WO2017011769A2 (en)	2015-07-15	2017-01-19	California Institute Of Technology	Il-17f-specific capture agents, compositions, and methods of using and making
JP6991148B2 (ja)	2016-02-09	2022-01-12	ブラッコ・スイス・ソシエテ・アノニム	セレクチン標的化のための組み換えキメラタンパク質
US20170319722A1 (en)	2016-04-04	2017-11-09	Indi Molecular, Inc.	Cd8-specific capture agents, compositions, and methods of using and making
WO2018064597A1 (en)	2016-09-29	2018-04-05	Indi Molecular, Inc.	Compositions for detection, inhibition and imaging of indoleamine 2,3-dioxygenase 1 (ido1) and methods of making and using same
WO2018085375A1 (en)	2016-11-01	2018-05-11	Ohio State Innovation Foundation	Methods for the iodination of biomolecules
WO2018232345A1 (en)	2017-06-15	2018-12-20	Indi Molecular, Inc.	Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
WO2020097531A1 (en)	2018-11-08	2020-05-14	Indi Molecular, Inc.	Theranostic capture agents, compositions, and methods of using and making
US20200291391A1 (en)	2019-03-12	2020-09-17	Indi Molecular, Inc.	Cross-linked epitopes and methods of use thereof
US20220218834A1 (en)	2019-05-20	2022-07-14	Ohio State Innovation Foundation	Apohemoglobin-haptoglobin complexes and methods of using thereof
US12216122B2 (en)	2019-05-20	2025-02-04	Regeneron Pharmaceuticals, Inc.	Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
US11414460B2 (en)	2019-07-19	2022-08-16	Institute For Systems Biology	KRAS-specific capture agents, compositions, and methods of making and using
WO2022098743A1 (en)	2020-11-03	2022-05-12	Indi Molecular, Inc.	Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
WO2022098745A1 (en)	2020-11-03	2022-05-12	Indi Molecular, Inc.	Compositions, delivery systems, and methods useful in tumor therapy
CA3227425A1 (en)	2021-07-26	2023-02-02	Arvinas Operations, Inc.	Methods of manufacturing a bifunctional compound
WO2025245032A1 (en)	2024-05-20	2025-11-27	Arvinas Operations, Inc.	Methods of manufacturing a bifunctional compound

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4390528A (en) *	1981-11-16	1983-06-28	Research Corporation	Tuftsinyl-tuftsin
US4980147A (en) *	1984-06-25	1990-12-25	University Of Utah Research Foundation	Radiolabeled technetium chelates for use in renal function determinations
FR2575753B1 (fr) *	1985-01-07	1987-02-20	Adir	Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5187264A (en) *	1986-05-28	1993-02-16	Mallinckrodt Medical, Inc.	Technetium chelates to be used for determining the renal function
ATE52516T1 (de) *	1986-05-28	1990-05-15	Mallinckrodt Inc	Technetiumchelate fuer die bestimmung der nierenfunktion.
US5082930A (en) *	1986-05-29	1992-01-21	Mallinckrodt Medical, Inc.	Coupling agents for joining radionuclide metal ions with biologically useful proteins
FR2610934B1 (fr) *	1987-02-13	1989-05-05	Adir	Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4965392A (en) *	1987-03-26	1990-10-23	Neorx Corporation	Chelating compounds for metal-radionuclide labeled proteins
US5091514A (en) *	1987-03-26	1992-02-25	Neorx Corporation	Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
FR2616663B1 (fr) *	1987-06-16	1989-08-18	Adir	Nouveaux tripeptides a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5021567A (en) *	1987-09-24	1991-06-04	Abbott Laboratories	8-hydroxyquinoline chelating agents
US5202451A (en) *	1988-02-17	1993-04-13	Neorx Corporation	Anchimeric radiometal chelating compounds
US5202109A (en) *	1988-06-10	1993-04-13	Neorx Corporation	Conjugates for bone imaging and bone cancer therapy
IT1230712B (it) *	1989-02-10	1991-10-29	Sclavo Spa	Composizione per vaccini
WO1990009172A1 (en) *	1989-02-16	1990-08-23	Pfizer Inc.	Phosphorus containing renin inhibitors
US4986979A (en) *	1989-03-14	1991-01-22	Neorx Corporation	Imaging tissue sites of inflammation
US5248764A (en) *	1989-06-16	1993-09-28	Merck Frosst Canada, Inc.	Chelate derivatives of atrial natriuretic factor (ANF)
US5028593A (en) *	1989-08-15	1991-07-02	Board Of Regents, The University Of Texas System	Tuftsin analogs
IT1232311B (it) *	1989-09-04	1992-01-28	Sclavo Spa	Metodo di purificazione di composti a struttura peptidica o pseudo peptidica a basso peso molecolare.
US5175257A (en) *	1989-12-29	1992-12-29	Neorx Corporation	Radiolabeled proteins for diagnostic or therapeutic use
EP0454302A3 (en) *	1990-03-30	1992-10-14	Banyu Pharmaceutical Co., Ltd.	Tuftsin derivatives
US5112594A (en) *	1991-04-04	1992-05-12	Mallinckrodt Medical, Inc.	Kit for preparing a technetium-99m myocardial imaging agent
EP0570493B1 (de) *	1991-02-08	2000-01-05	Diatide, Inc.	Technetium-99m markierte Polypeptide zur Bildformung
AU1995392A (en) *	1991-05-08	1992-12-21	Mallinckrodt Medical, Inc.	Technetium chelates to be used for determining the renal function
AU683833B2 (en) *	1992-01-03	1997-11-27	Rhomed Incorporated	Protein- and peptide-metal ion pharmaceutical applications
GB9209641D0 (en) *	1992-05-02	1992-06-17	Johnson Matthey Plc	Improvements in radiolabelling
EP0710228B1 (de) *	1993-07-19	1998-01-21	Resolution Pharmaceuticals Inc.	Hydrazine mit einer n3s konfiguration als radionukleide chelatoren
EP0730472B1 (de) *	1993-11-16	2006-08-02	Bracco International B.V.	Immobilisiertes markierungsverfahren
US5480970A (en) *	1993-12-22	1996-01-02	Resolution Pharmaceuticals	Metal chelators
US5569745A (en) *	1994-02-25	1996-10-29	Resolution Pharmaceuticals Inc.	Peptide-Chelator conjugates
US5662885A (en) *	1994-07-22	1997-09-02	Resolution Pharmaceuticals Inc.	Peptide derived radionuclide chelators
US5804158A (en) *	1995-05-31	1998-09-08	Resolution Pharmaceuticals Inc.	Sequestered imaging agents

1994
- 1994-07-22 US US08/279,155 patent/US5662885A/en not_active Expired - Lifetime
1995
- 1995-04-28 DE DE69518083T patent/DE69518083T2/de not_active Expired - Lifetime
- 1995-04-28 JP JP50532396A patent/JP3753734B2/ja not_active Expired - Fee Related
- 1995-04-28 AU AU23011/95A patent/AU700772B2/en not_active Ceased
- 1995-04-28 HU HU9700196A patent/HUT77137A/hu unknown
- 1995-04-28 CA CA002194551A patent/CA2194551A1/en not_active Abandoned
- 1995-04-28 AT AT95916539T patent/ATE194845T1/de not_active IP Right Cessation
- 1995-04-28 WO PCT/CA1995/000249 patent/WO1996003427A1/en not_active Ceased
- 1995-04-28 US US08/612,842 patent/US5976495A/en not_active Expired - Lifetime
- 1995-04-28 CN CN95195127A patent/CN1158133A/zh active Pending
- 1995-04-28 EP EP95916539A patent/EP0772628B1/de not_active Expired - Lifetime
1996
- 1996-08-28 US US08/703,988 patent/US5780006A/en not_active Expired - Lifetime
1997
- 1997-01-21 NO NO970273A patent/NO970273L/no unknown

Also Published As

Publication number	Publication date
EP0772628A1 (de)	1997-05-14
DE69518083T2 (de)	2001-03-22
CN1158133A (zh)	1997-08-27
NO970273D0 (no)	1997-01-21
AU700772B2 (en)	1999-01-14
ATE194845T1 (de)	2000-08-15
US5780006A (en)	1998-07-14
US5662885A (en)	1997-09-02
WO1996003427A1 (en)	1996-02-08
HUT77137A (hu)	1998-03-02
DE69518083D1 (de)	2000-08-24
EP0772628B1 (de)	2000-07-19
JPH10502931A (ja)	1998-03-17
CA2194551A1 (en)	1996-02-08
JP3753734B2 (ja)	2006-03-08
US5976495A (en)	1999-11-02
AU2301195A (en)	1996-02-22

Publication	Publication Date	Title
NO970273L (no)	1997-03-12	Peptid-avledete radionuklid-chelatorer
NL7701457A (nl)	1977-08-16	Werkwijze ter bereiding van nieuwe prolinederi- vaten en verwante verbindingen.
EA200100755A1 (ru)	2001-12-24	4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
SE8401135D0 (sv)	1984-03-01	Forfarande for framstellning av iso-cyklosporin d
NZ217419A (en)	1989-03-29	Indole derivatives and pharmaceutical compositions
SE7906533L (sv)	1980-02-03	Pyrrolidinderivat
TR199900874T2 (xx)	1999-07-21	Heteroaril s�ksinamidler ve metalloproteinaz inhibit�r� olarak kullan�mlar�.
PE43597A1 (es)	1997-12-26	Procedimiento y derivados de n-(3-benzofuranil)urea
DK116480A (da)	1980-09-21	Fremgangsmaade til fremstilling af substituerede chromoner
DK157848C (da)	1990-07-23	Analogifremgangsmaade til fremstilling af 2-(3-hydroxy-2-oxo-1-pyrrolidinyl)carboxylsyreamidderivater samt et udgangsmateriale til anvendelse ved denne fremgangsmaade
NO165921C (no)	1991-05-02	Fremgangsmaate for fremstilling av disubstituerte prolinderivater.
ATE209187T1 (de)	2001-12-15	Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
DK432086D0 (da)	1986-09-10	Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf
DE69524064D1 (de)	2002-01-03	Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
RU1833365C (ru)	1993-08-07	Cпocoб пoлучehия tpииoдбehзoльhыx coeдиhehий
ATE61355T1 (de)	1991-03-15	2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung.
ATE154032T1 (de)	1997-06-15	Neue d-homo-17-oxa und d-homo-17-aza- androstanderivate
DK82583D0 (da)	1983-02-23	Furyloxazolyleddikesyrederivater og fremgangsmader til fremstilling deraf
ES454265A1 (es)	1977-12-01	Un procedimiento para la obtencion de nuevas cefalosporinas.
NO990226L (no)	1999-07-21	1-isotiazolidinon-derivater av azetidin-2-on, fremgangsmåter for fremstilling og anvendelse derav
ATE210456T1 (de)	2001-12-15	Verwendung der seminalribonuklease als antimetastatische verbindung
GB2008122A (en)	1979-05-31	Sarcosine<1> Dehydroalanine<8> angiotensin II Derivatives
SE8203245L (sv)	1982-11-28	Forfarande for enantioselektiv framstellning av n-substituerade prolinderivat
ES528460A0 (es)	1985-10-01	Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias.
SE8008536L (sv)	1981-06-07	2,5-dialkylfenkylkarbamidderivat, forfarande for framstellning derav, herbicidiska kompositioner innehallande nemnda derivat samt sett att bekempa ogres under utnyttjande av derivaten